
Kyverna Therapeutics, Inc.
USD7.48
+0.24 (+3.31%)
CEO
Warner Biddle
IPO Date
2024-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.25
Prev. Close
$7.24
Day Low
$7.15
Day High
$7.52
52W Low
$2.80
52W High
$13.67
Market Cap
$0.33B
Volume
0.88M
| 23 Apr 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 16 Dec 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 4 Dec 2025 | Morgan Stanley | Overweight | Overweight | maintain |
| 30 Oct 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 27 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Oct 2025 | Wells Fargo | Overweight | Overweight | maintain |
| 29 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |